VB-201

· Vascular Biogenics Ltd. (VBL Therapeutics)

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for VB-201, covering 2011-11-16 to 2023-02-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 [Phase 2]